Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer. Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune...
Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer. Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune...
You must be a Standard 1 Year member to access this content.